Download Files:
Mal-PEG8-Val-Cit-PAB-MMAF
$650 – $1,630
Products Details
Product Description
– Mal-PEG8-Val-Cit-PAB-MMAF is a drug-linker conjugate for ADC. Mal-PEG8-Val-Cit-PAB-MMAF contains a cleavable ADC linker and a potent tubulin inhibitor MMAE (HY-15162)[1].
Web ID
– HY-156758
Storage Temperature
– -20°C, 3 years; 4°C, 2 years (Powder)
Shipping
– Room Temperature
Molecular Formula
– C81H129N11O24
References
– [1]Beck A, et al. Strategies and challenges for the next generation of antibody-drug conjugates. Nat Rev Drug Discov. 2017 May;16(5):315-337.
Molecular Weight
– 1640.95
Compound Purity
– 96.50
SMILES
– O=C(CCOCCOCCOCCOCCOCCOCCOCCOCCN1C(C=CC1=O)=O)N[C@H](C(N[C@H](C(NC2=CC=C(COC(N([C@H](C(N[C@H](C(N([C@H]([C@@H](CC(N3[C@]([H])([C@@H]([C@H](C(N[C@@H](CC4=CC=CC=C4)C(O)=O)=O)C)OC)CCC3)=O)OC)[C@H](CC)C)C)=O)C(C)C)=O)C(C)C)C)=O)C=C2)=O)CCCNC(N)=O)=O)C(C)C
Clinical Information
– No Development Reported
Research Area
– Cancer
Solubility
– 10 mM in DMSO
Target
– Drug-Linker Conjugates for ADC
Pathway
– Antibody-drug Conjugate/ADC Related
Product type
– ADC Related
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
